Singapore markets closed

ZyVersa Therapeutics, Inc. (ZVSA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
5.37+0.09 (+1.70%)
At close: 04:00PM EDT
5.17 -0.20 (-3.72%)
After hours: 07:27PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close5.28
Open5.18
Bid5.12 x 100
Ask5.53 x 100
Day's range5.16 - 5.44
52-week range4.44 - 180.25
Volume61,385
Avg. volume410,148
Market cap4.078M
Beta (5Y monthly)0.66
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Benzinga

    Why Is Inflammatory Disease-Focused ZyVersa Therapeutics Stock Trading Higher Today?

    ZyVersa Therapeutics Inc (NASDAQ:ZVSA) announces the publication of an article in the peer-reviewed journal Acta Neuropathologica Communications, demonstrating that inflammasome activation enhances cancer metastasis to the brain in women with triple-negative breast cancer (TNBC). Up to 40% of women with TNBC experience metastasis to their brain. Published data demonstrate that inflammasome activation increases the proliferation of TNBC cells in the brain, which was prevented by inhibition of NLR